Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target.
Shao Y, Xu K, Zheng X, Zhou B, Zhang X, Wang L, Sun Y, Li D, Chen T, Wang J, Yu S, Sun L, Xu X, Dai S, Gao H, Ruan G, Liu W, Cai X, Zhu T, Qi L, Chen J, Hu W, Weng X, Zhu Y, Xiang X, Hu Z, Li J, Chen L, Shao J, Zheng S, Guo T.
Shao Y, et al. Among authors: chen j, chen l, chen t.
Cancer Commun (Lond). 2022 Feb;42(2):164-169. doi: 10.1002/cac2.12240. Epub 2021 Dec 4.
Cancer Commun (Lond). 2022.
PMID: 34862750
Free PMC article.
No abstract available.